Glaxosmithkline Share Price | |
---|---|
Price | 1,670.00 |
Bid | 1,670.50 |
Ask | 1,671.00 |
Change | 17.00 (1.03%) |
Volume | 5,910,992 |
Open | 1,650.00 |
High | 1,677.00 |
Low | 1,646.00 |
Prev. Close | 1,653.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.09b |
Market Capitalisation | £68.24b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 8,491 |
---|---|
Vol. Sold | 1,424,217 |
Sold Value | £23.74m |
Vol. Bought | 4,261,147 |
Bought Value | £71.09m |
PE Ratio | 13.73355 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.323% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
29-Apr-24 | 17:41:12 | 1,672.75 | 14,175 | Unknown* | 1,670.50 | 1,671.00 | 237.11k | O Ordinary |
29-Apr-24 | 17:41:12 | 1,672.75 | 14,175 | Unknown* | 1,670.50 | 1,671.00 | 237.11k | O Ordinary |
29-Apr-24 | 10:12:20 | 1,653.00 | 2,011 | Unknown* | 1,670.50 | 1,671.00 | 33.24k | O Ordinary Delayed publication Trade was executed as an SI |
29-Apr-24 | 16:14:35 | 1,670.00 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
29-Apr-24 | 16:14:36 | 1,670.00 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
29-Apr-24 | 16:14:35 | 1,670.00 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
29-Apr-24 | 16:14:35 | 1,670.00 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
29-Apr-24 | 16:19:56 | 1,670.50 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
29-Apr-24 | 16:19:56 | 1,670.50 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
29-Apr-24 | 16:19:56 | 1,670.50 | 0 | Unknown* | 1,670.50 | 1,671.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
At GSK, we unite science, technology and talent to get ahead of disease together